June 14, 2021

Isofol raises SEK 500 million in oversubscribed rights issue and exercised over-allotment option

Link to the press release >>

March 19, 2021

Isofol receives recommendation from iDSMB to complete the AGENT study for market registration as planned with 440 patients

Link to the press release >>

See how arfolitixorin
works in cancer cells

See the animation >>

Previous

Next

Startpage 2

Upcoming Events

  • August 24, 2021 - August 24, 2021
    Interim Report Q2 2021
  • September 01, 2021 - September 01, 2021
    Pareto Securities´ Healthcare Conference, Stockholm
  • September 06, 2021 - September 17, 2021
    LSX Nordic Congress Virtual Showcase
  • November 15, 2021 - November 15, 2021
    Interim Report Q3 2021